Cardiac Dimensions, Inc. Completes Patient Enrollment in TITAN II Clinical Trial
3/8/2013 9:44:27 AM
More...
|
Cardiac Dimensions, Inc. Initiates European Commercialization of CARILLON® Mitral Contour System®
9/28/2012 11:17:54 AM
More...
|
Cardiac Dimensions, Inc. Nabs $5.8 Million for Heart Failure Device
9/13/2012 8:33:19 AM
More...
|
Cardiac Dimensions, Inc. Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
5/22/2012 10:27:07 AM
More...
|
Cardiac Dimensions, Inc. Names Omari V. Bouknight Vice President of Sales and Marketing
10/13/2011 10:02:59 AM
More...
|
Cardiac Dimensions, Inc. Announces First Patient Treated in TITAN II Clinical Trial
10/11/2011 6:00:35 AM
More...
|
Cardiac Dimensions, Inc. Receives CE Mark Approval for Enhanced CARILLON(R) Mitral Contour System(TM), Aims for Market in 2012
9/30/2011 6:01:34 AM
More...
|
Cardiac Dimensions, Inc. Announces Expansion of Clinical Reach With Initiation of Two New Clinical Studies of its CARILLON(R) Mitral Contour System(TM)
5/4/2011 7:40:03 AM
More...
|
Washington Startups Like Cardiac Dimensions, Inc. and Generic Medical Devices, Inc. Collect $24M in November, Med Devices Lead the Way
12/17/2010 8:02:18 AM
More...
|
Cardiac Dimensions, Inc. Presentation of 12-Month Follow-up Data of TITAN(TM) Trial at European Society of Cardiology Meeting
8/18/2010 9:09:15 AM
More...
|
|